Top Markets
#1 Black Phoenix Black Phoenix +355.13%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.86%
#4 OpenEden OpenEden +60.23%
#5 Akedo Akedo +56.95%
#6 BasedHype BasedHype +26.68%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +19.51%
#9 Humanity Humanity +19.18%
#10 Ether.fi Ether.fi +17.32%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Verisante Technology Inc. Verisante Technology Inc.

Verisante Technology Inc.

VRSEF
Rang in aandelen #40371
Verisante Technology Inc. presently lacks substantial business operations.... Verisante Technology Inc. presently lacks substantial business operations. Historically, the company focused on developing and manufacturing advanced diagnostic devices for cancer. Originally founded as T-Ray Science Inc., it adopted its current name, Verisante Technology Inc., in January 2011. The firm was established in 2006 and is headquartered in Vancouver, Canada.
Aandeelprijs
$0.0011
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$164.53K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-72.50%
Land
CA
Handel Verisante Technology Inc. (VRSEF)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Verisante Technology Inc. (VRSEF)
Het dividendrendement (TTM) van Verisante Technology Inc. (aandelsymbool: VRSEF) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Verisante Technology Inc. (VRSEF) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.35%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.07%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US